AU4788396A - Inhibition of angiogenesis using interleukin-12 - Google Patents

Inhibition of angiogenesis using interleukin-12

Info

Publication number: AU4788396A
Authority: AU; Australia
Prior art keywords: angiogenesis; interleukin; inhibition
Prior art date: 1995-02-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU47883/96A

Other languages

English (en)

Inventor

Moses Judah Folkman

Gary Arthur Truitt

Emile Eugene Voest

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

F Hoffmann La Roche AG

Boston Childrens Hospital

Original Assignee

HOFFMANN LA ROCHE

F Hoffmann La Roche AG

Boston Childrens Hospital

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-16

Filing date

1996-02-07

Publication date

1996-09-04

1996-02-07 Application filed by HOFFMANN LA ROCHE, F Hoffmann La Roche AG, Boston Childrens Hospital filed Critical HOFFMANN LA ROCHE

1996-09-04 Publication of AU4788396A publication Critical patent/AU4788396A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/208—IL-12
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Emergency Medicine (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Zoology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Ophthalmology & Optometry (AREA)
Dermatology (AREA)
Virology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AU47883/96A 1995-02-16 1996-02-07 Inhibition of angiogenesis using interleukin-12 Abandoned AU4788396A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US38938295A	1995-02-16	1995-02-16
US389382		1995-02-16
PCT/EP1996/000507 WO1996025171A1 (en)	1995-02-16	1996-02-07	Inhibition of angiogenesis using interleukin-12

Publications (1)

Publication Number	Publication Date
AU4788396A true AU4788396A (en)	1996-09-04

Family

ID=23538033

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU47883/96A Abandoned AU4788396A (en)	1995-02-16	1996-02-07	Inhibition of angiogenesis using interleukin-12

Country Status (8)

Country	Link
EP (1)	EP0809511A1 (fi)
JP (1)	JPH11500119A (fi)
AU (1)	AU4788396A (fi)
BR (1)	BR9607427A (fi)
CA (1)	CA2212370A1 (fi)
FI (1)	FI973356L (fi)
TR (1)	TR199700801T1 (fi)
WO (1)	WO1996025171A1 (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998022129A1 (fr) *	1996-11-22	1998-05-28	Toray Industries, Inc.	Agent therapeutique pour maladies ophtalmiques
US5858991A (en)	1997-01-29	1999-01-12	Vanderbilt University	Facilitation of wound healing with CM101/GBS toxin
US5981508A (en) *	1997-01-29	1999-11-09	Vanderbilt University	Facilitation of repair of neural injury with CM101/GBS toxin
US6028060A (en) *	1997-01-29	2000-02-22	Vanderbilt University	Treatment of chronic inflammatory diseases with CM101/GBS toxin
US6670337B1 (en)	1998-01-29	2003-12-30	Yeda Reaearch And Development Co., Ltd.	Facilitation of wound healing with CM101/GBS toxin
US6660258B1 (en)	1997-05-09	2003-12-09	Pharma Pacific Pty Ltd	Oromucosal cytokine compositions and uses thereof
WO1998053835A1 (en) *	1997-05-27	1998-12-03	The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services	The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer
EP1030681A4 (en) *	1997-11-03	2001-07-04	Wistar Inst	METHOD AND COMPOSITIONS FOR INHIBITING ANGIOGENESIS AND TREATING CANCER
EP1373206B1 (en)	2001-03-29	2008-12-24	Schering Corporation	Aryl oxime-piperazines useful as ccr5 antagonists
AU2003292838A1 (en) *	2002-12-27	2004-07-29	Kirin Beer Kabushiki Kaisha	Therapeutic agent for wet age-related macular degeneration
MXPA05010081A (es)	2003-03-24	2005-11-23	Hoffmann La Roche	Bencil-piridazinonas como inhibidores de transcriptasa inversa.
WO2007045573A1 (en)	2005-10-19	2007-04-26	F. Hoffmann-La Roche Ag	Phenyl-acetamide nnrt inhibitors
KR101401811B1 (ko)	2006-08-16	2014-05-29	에프. 호프만-라 로슈 아게	비-뉴클레오사이드 역전사효소 저해제
ES2550152T3 (es)	2006-12-13	2015-11-04	F. Hoffmann-La Roche Ag	Derivados de 2-(piperidin-4-il)-4-fenoxi-o fenilamino-pirimidina como inhibidores no nucleósidos de transcriptasa inversa
CN109789187A (zh) *	2016-07-18	2019-05-21	创新疗法医药有限公司	Il-12作为替代免疫治疗剂的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0576669A4 (en) *	1992-01-16	1996-05-08	Repligen Corp	Novel methods and compositions for treatment of angiogenic diseases
JPH06157344A (ja) *	1992-02-07	1994-06-03	Childrens Medical Center Corp:The	血管新生阻害のための医薬製剤及び血管新生阻害方法

1996
- 1996-02-07 CA CA002212370A patent/CA2212370A1/en not_active Abandoned
- 1996-02-07 WO PCT/EP1996/000507 patent/WO1996025171A1/en not_active Application Discontinuation
- 1996-02-07 TR TR97/00801T patent/TR199700801T1/xx unknown
- 1996-02-07 JP JP8524631A patent/JPH11500119A/ja active Pending
- 1996-02-07 EP EP96904008A patent/EP0809511A1/en not_active Withdrawn
- 1996-02-07 BR BR9607427A patent/BR9607427A/pt not_active Application Discontinuation
- 1996-02-07 AU AU47883/96A patent/AU4788396A/en not_active Abandoned
1997
- 1997-08-15 FI FI973356A patent/FI973356L/fi unknown

Also Published As

Publication number	Publication date
FI973356A0 (fi)	1997-08-15
WO1996025171A1 (en)	1996-08-22
FI973356L (fi)	1997-08-15
JPH11500119A (ja)	1999-01-06
TR199700801T1 (tr)	1998-03-21
MX9706188A (es)	1997-11-29
BR9607427A (pt)	1998-06-23
CA2212370A1 (en)	1996-08-22
EP0809511A1 (en)	1997-12-03

Publication	Publication Date	Title
PL322277A1 (en)	1998-01-19	Derivatives of pyrazol-4-ylobenzoyl
AU5893696A (en)	1996-12-30	Modification of polypeptides
AU5457096A (en)	1996-10-31	Gene-transfer-mediated angiogenesis therapy
AU7038496A (en)	1997-05-01	Angiogenesis inhibitor
AU5893796A (en)	1996-12-30	Modification of polypeptides
AU3299195A (en)	1996-04-18	Inhibition of helicobacter
PL324451A1 (en)	1998-05-25	Derivatives of diphenylmethylenepiperidine
AU7456396A (en)	1997-05-22	Inhibition of amyloidosis by 9-acridinones
AU4329396A (en)	1996-07-31	Use of 3,4-diphenylchromans
ZA969221B (en)	1998-05-04	Indolealkyl derivatives of benzodioxanmethylamine.
GB9512290D0 (en)	1995-08-16	Uses of polyhexanide
AU4788396A (en)	1996-09-04	Inhibition of angiogenesis using interleukin-12
HUP9602510A1 (en)	1997-05-28	Preparation of substituted thiazoles
IL116924A0 (en)	1996-05-14	Preparation of n-aryl- and n-hetarylhydroxylamines
AU5381696A (en)	1996-10-16	Synthesis of bis-indolylmaleimides
AU5157796A (en)	1996-10-16	Whipstock
AU2217797A (en)	1997-10-10	Synthesis of indolylmaleimides
AU4224096A (en)	1996-08-08	Use of phenylcyclohexylcarboxamides
AU4157097A (en)	1998-03-06	Synthesis of bisindolylmalimides
AU4396396A (en)	1996-08-07	Baby-bathing aid
AU4877196A (en)	1996-09-18	Derivatives of 3-pyrrolidylidene-2-one-cephalosporines
AU3948395A (en)	1996-05-06	Synthesis of 6-azaandrostenones
AU5126298A (en)	1998-06-03	Inhibition of crib-biting
AU2993095A (en)	1996-12-18	Cyclone
AU7396996A (en)	1997-04-30	Anchor